Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-14-023924
Filing Date
2014-04-22
Accepted
2014-04-21 17:42:26
Documents
7
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v375384_10ka.htm 10-K/A 1145700
  Complete submission text file 0001144204-14-023924.txt   11329327

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ambse-20131231.xml EX-101.INS 1960254
3 XBRL TAXONOMY EXTENSION SCHEMA ambse-20131231.xsd EX-101.SCH 135423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ambse-20131231_cal.xml EX-101.CAL 45578
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ambse-20131231_def.xml EX-101.DEF 540235
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ambse-20131231_lab.xml EX-101.LAB 633893
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ambse-20131231_pre.xml EX-101.PRE 622646
Mailing Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-55016 | Film No.: 14774663
SIC: 2834 Pharmaceutical Preparations